Luye Pharma Group Ltd - Asset Resilience Ratio

Latest as of December 2025: 9.15%

Luye Pharma Group Ltd (LUP) has an Asset Resilience Ratio of 9.15% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Luye Pharma Group Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€3.00 Billion

≈ $3.51 Billion USD Cash + Short-term Investments

Total Assets

€32.83 Billion

≈ $38.38 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Luye Pharma Group Ltd's Asset Resilience Ratio has changed over time. See Luye Pharma Group Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Luye Pharma Group Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Luye Pharma Group Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€3.00 Billion	9.15%
Total Liquid Assets	€3.00 Billion	9.15%

Asset Resilience Insights

Limited Liquidity: Luye Pharma Group Ltd maintains only 9.15% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Luye Pharma Group Ltd Industry Peers by Asset Resilience Ratio

Compare Luye Pharma Group Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Tianjin Zhongxin Pharmaceutical Group Corp Ltd SHG:600329	Drug Manufacturers - Specialty & Generic	5.92%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Dermapharm Holding SE XETRA:DMP	Drug Manufacturers - Specialty & Generic	1.23%
China Animal Husbandry Industry Co Ltd SHG:600195	Drug Manufacturers - Specialty & Generic	3.81%
Daewoong Pharma KO:069620	Drug Manufacturers - Specialty & Generic	0.19%
Guizhou Bailing Group Pharmaceutical Co Ltd SHE:002424	Drug Manufacturers - Specialty & Generic	2.09%

Annual Asset Resilience Ratio for Luye Pharma Group Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Luye Pharma Group Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	9.15%	€3.00 Billion ≈ $3.51 Billion	€32.83 Billion ≈ $38.38 Billion	+3.86pp
2024-12-31	5.29%	€1.57 Billion ≈ $1.83 Billion	€29.61 Billion ≈ $34.62 Billion	-5.96pp
2023-12-31	11.25%	€2.87 Billion ≈ $3.35 Billion	€25.49 Billion ≈ $29.80 Billion	-2.03pp
2022-12-31	13.28%	€3.22 Billion ≈ $3.77 Billion	€24.25 Billion ≈ $28.35 Billion	-0.32pp
2021-12-31	13.60%	€3.07 Billion ≈ $3.59 Billion	€22.58 Billion ≈ $26.40 Billion	+6.13pp
2020-12-31	7.47%	€1.54 Billion ≈ $1.80 Billion	€20.63 Billion ≈ $24.12 Billion	-7.35pp
2019-12-31	14.82%	€2.86 Billion ≈ $3.35 Billion	€19.31 Billion ≈ $22.58 Billion	-3.36pp
2018-12-31	18.19%	€3.19 Billion ≈ $3.73 Billion	€17.54 Billion ≈ $20.50 Billion	-5.75pp
2017-12-31	23.93%	€2.58 Billion ≈ $3.01 Billion	€10.76 Billion ≈ $12.58 Billion	-1.59pp
2016-12-31	25.52%	€2.35 Billion ≈ $2.75 Billion	€9.21 Billion ≈ $10.76 Billion	--

pp = percentage points

About Luye Pharma Group Ltd

F:LUP Germany Drug Manufacturers - Specialty & Generic

Market Cap

$1.02 Billion

€870.80 Million EUR

Market Cap Rank

#8996 Global

#1142 in Germany

Share Price

€0.22

Change (1 day)

+2.83%

52-Week Range

€0.19 - €0.48

All Time High

€0.70